Luminex (Nasdaq: LMNX) reported earnings on April 29. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended March 31 (Q1), Luminex beat expectations on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue grew. Non-GAAP earnings per share grew significantly. GAAP earnings per share shrank to a loss.

Gross margins grew, operating margins dropped, net margins dropped.

Revenue details
 Luminex logged revenue of $53.2 million. The 10 analysts polled by S&P Capital IQ looked for sales of $51.8 million on the same basis. GAAP reported sales were 9.2% higher than the prior-year quarter's $48.7 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.11. The nine earnings estimates compiled by S&P Capital IQ forecast $0.08 per share. Non-GAAP EPS of $0.11 for Q1 were 38% higher than the prior-year quarter's $0.08 per share. GAAP EPS were -$0.06 for Q1 against $0.08 per share for the prior-year quarter.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 71.3%, 200 basis points better than the prior-year quarter. Operating margin was -2.9%, much worse than the prior-year quarter. Net margin was -4.7%, much worse than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
 Next quarter's average estimate for revenue is $54.3 million. On the bottom line, the average EPS estimate is $0.10.

Next year's average estimate for revenue is $224.3 million. The average EPS estimate is $0.43.

Investor sentiment
 The stock has a one-star rating (out of five) at Motley Fool CAPS, with 90 members out of 105 rating the stock outperform, and 15 members rating it underperform. Among 26 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 20 give Luminex a green thumbs-up, and six give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Luminex is hold, with an average price target of $18.40.

Looking for alternatives to Luminex? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.